Mike Fitzgibbons Interviewed by BioXconomy on Access Analytics Product Launch
In a rapidly evolving healthcare landscape, life sciences organizations face mounting challenges in market access—particularly when it comes to rare and specialty diseases. Fragmented data sources, delays in reporting, and lack of actionable insights often create barriers for patients in need of timely therapy. In a recent interview with BioXconomy, Claritas Rx CEO Mike Fitzgibbons shares how Access Analytics is […]
Mike Fitzgibbons Interviewed by BioXconomy on Access Analytics Product Launch Read More »









